Hot water extracts of edible Chrysanthemum morifolium Ramat. exert antidiabetic effects in obese diabetic KK-A^y mice

References

• Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat. Med. 2006;12:75–80.10.1038/nm0106-75
   PubMed Web of Science ®Google Scholar
• Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 1998;101:1354–1361.10.1172/JCI1235
   PubMed Web of Science ®Google Scholar
• Rosen ED. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent. Fatty Acids 2005;73:31–34.10.1016/j.plefa.2005.04.004
   PubMed Web of Science ®Google Scholar
• Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes. 2003;52:1655–1663.10.2337/diabetes.52.7.1655
   PubMed Web of Science ®Google Scholar
• Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Invest. 2000;106:459–465.10.1172/JCI10830
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001;7:941–946.10.1038/90984
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361:226–228.10.1016/S0140-6736(03)12255-6
   PubMed Web of Science ®Google Scholar
• Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005;25:2062–2068.10.1161/01.ATV.0000183883.72263.13
   PubMed Web of Science ®Google Scholar
• Hirai S, Takahashi N, Goto T, Lin S, Uemura T, Yu R, Kawada T. Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. Mediators Inflamm. 2010;2010. Article ID 367838, 8 pages.
   Web of Science ®Google Scholar
• Gustafson B. Adipose tissue, inflammation and atherosclerosis. J. Atheroscler. Thromb. 2010;17:332–341.10.5551/jat.3939
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. (Lond). 2008;32:S13–18.10.1038/ijo.2008.233
   PubMed Web of Science ®Google Scholar
• Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50:2094–2099.10.2337/diabetes.50.9.2094
   PubMed Web of Science ®Google Scholar
• Evans RM, Barish GD, Wang Y-X. PPARs and the complex journey to obesity. Nat. Med. 2004;10:355–361.10.1038/nm1025
   PubMed Web of Science ®Google Scholar
• Bodles AM, Varma V, Yao-Borengasser A, Phanavanh B, Peterson CA, McGehee RE, Rasouli N, Wabitsch M, Kern PA. Pioglitazone induces apoptosis of macrophages in human adipose tissue. J. Lipid Res. 2006;47:2080–2088.10.1194/jlr.M600235-JLR200
   PubMed Web of Science ®Google Scholar
• Scheen AJ. Thiazolidinediones and liver toxicity. Diabetes Metab. 2001;27:305–313.
   PubMed Web of Science ®Google Scholar
• Shah P, Mudaliar S. Pioglitazone: side effect and safety profile. Expert Opin. Drug Saf. 2010;9:347–354.10.1517/14740331003623218
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee YS. Identification of new dicaffeoylquinic acids from Chrysanthemum morifolium and their antioxidant activities. Planta Med. 2005;71:871–876.10.1055/s-2005-873115
   PubMed Web of Science ®Google Scholar
• Ukiya M, Akihisa T, Yasukawa K, Kasahara Y, Kimura Y, Koike K, Nikaido T, Takido M. Constituents of compositae plants. 2. triterpene diols, triols, and their 3- o -fatty acid esters from edible chrysanthemum flower extract and their anti-inflammatory effects. J. Agric. Food. Chem. 2001;49:3187–3197.10.1021/jf010164e
   PubMed Web of Science ®Google Scholar
• Miyazawa M, Hisama M. Antimutagenic activity of flavonoids from Chrysanthemum morifolium. Biosci. Biotechnol. Biochem. 2003;67:2091–2099.10.1271/bbb.67.2091
   PubMed Web of Science ®Google Scholar
• Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, Kumaki K, Tamura T. Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry. 1996;43:1255–1260.10.1016/S0031-9422(96)00343-3
   PubMed Web of Science ®Google Scholar
• Hu CQ, Chen K, Shi Q, Kilkuskie RE, Cheng YC, Lee KH. Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids. J. Nat. Prod. 1994;57:42–51.10.1021/np50103a006
   PubMed Web of Science ®Google Scholar
• Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993;123:1939–1951.
   PubMed Web of Science ®Google Scholar
• Sasaki R, Nishimura N, Hoshino H, Isa Y, Kadowaki M, Ichi T, Tanaka A, Nishiumi S, Fukuda I, Ashida H, Horio F, Tsuda T. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol. 2007;74:1619–1627.10.1016/j.bcp.2007.08.008
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 2005;26:439–451.10.1210/er.2005-0005
   PubMed Web of Science ®Google Scholar
• Goto T, Kim Y-I, Takahashi N, Kawada T. Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors. Mol. Nutr. Food Res. 2013;57:20–33.10.1002/mnfr.v57.1
   PubMed Web of Science ®Google Scholar
• Yamamoto J, Yamane T, Oishi Y, Shimizu M, Tadaishi M, Kobayashi-Hattori K. Chrysanthemum extract promotes adipocyte differentiation, adiponectin secretion, and glucose uptake. Am. J. Chin. Med. Forthcoming.
   Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 2001;276:41245–41254.10.1074/jbc.M103241200
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003;112:1821–1830.10.1172/JCI200319451
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003;112:1796–1808.10.1172/JCI200319246
   PubMed Web of Science ®Google Scholar
• Kawada T, Goto T, Hirai S, Kang M-S, Uemura T, Yu R, Takahashi N. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome. Asia Pac. J. Clin. Nutr. 2008;17(Suppl 1):126–130.
   PubMed Web of Science ®Google Scholar
• Ito A, Suganami T, Miyamoto Y, Yoshimasa Y, Takeya M, Kamei Y, Ogawa Y. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. J. Biol. Chem. 2007;282:25445–25452.10.1074/jbc.M701549200
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim HJ, Lee YS. A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium. Planta Med. 2003;69:859–861.
   PubMed Web of Science ®Google Scholar
• Sugawara T, Igarashi K. Cultivar variation in flavonoid components and radical scavenging activity of polyphenol fractions among edible chrysanthemum flowers. Nippon Shokuhin Kagaku Kogaku Kaishi. 2009;56:600–604.10.3136/nskkk.56.600
   Web of Science ®Google Scholar
• Meng S, Cao J, Feng Q, Peng J, Hu Y. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid. Based. Complement. Alternat. Med. 2013;2013:801457.
   PubMed Web of Science ®Google Scholar
• Xu N, Zhang L, Dong J, Zhang X, Chen Y-G, Bao B, Liu J. Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. Mol. Nutr. Food Res. 2014;58:1258–1268.10.1002/mnfr.v58.6
   PubMed Web of Science ®Google Scholar
• Panda S, Kar A. Apigenin (4’,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J. Pharm. Pharmacol. 2007;59:1543–1548.10.1211/jpp.59.11.0012
   PubMed Web of Science ®Google Scholar
• Hsu C-L, Huang S-L, Yen G-C. Inhibitory effect of phenolic acids on the proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity. J. Agric. Food. Chem. 2006;54:4191–4197.10.1021/jf0609882
   PubMed Web of Science ®Google Scholar
• Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 2008;74:667–677.
   PubMed Web of Science ®Google Scholar
• Upadhyay R, Mohan Rao LJ. An outlook on chlorogenic acids-occurrence, chemistry, technology, and biological activities. Crit. Rev. Food Sci. Nutr. 2013;53:968–984.10.1080/10408398.2011.576319
   PubMed Web of Science ®Google Scholar